Author:
Armijo-Olivo Susan,Fuentes Jorge,Rogers Todd,Hartling Lisa,Saltaji Humam,Cummings Greta G
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Higgins JPT, Altman DG, Goetzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC: The Cochrane collaboration’s tool for assessing risk of bias in randomized trials. BMJ. 2011, 343: 7829-Online
2. Khan K, Ter-Riet G, Popay J, Nixon J, Kleijnen J: Satge ii. Conducting the review. Phase 5 study quality assessment. Undertaking systematic reviews of research effectiveness CRD’s guidance for those carrying out or commissioning reviews. 2001, York: Center for Reviews and Dissemination, 1-20.
3. Pildal J, Hrobjartsson A, Jorgensen KJ, Hilden J, Altman DG, Gotzsche PC: Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol. 2007, 36 (4): 847-857. 10.1093/ije/dym087.
4. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJG, Sterne JAC: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008, 336 (7644): 601-605. 10.1136/bmj.39465.451748.AD.
5. Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Seida JK, Klassen TP: Risk of bias versus quality assessment of randomized controlled trials: cross sectional study. BMJ. 2009, 339 (7728): 1017-
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献